Back
Intra-Cellular Therapies Stock Price Chart
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!
Buy
63
ITCI
Intra-Cellular Therapies
Last Price:
89.41
Seasonality Move:
17.18%
7 Day Trial
ALL ACCESS PASS
$
7
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ITCI is experiencing buying pressure, which is a positive indicator for future bullish movement.
Intra-Cellular Therapies Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 82.69 | Buy |
| 20-day SMA: | 78.21 | Buy |
| 50-day SMA: | 75.65 | Buy |
| 200-day SMA: | 72.06 | Buy |
| 8-day EMA: | 83.84 | Buy |
| 20-day EMA: | 79.81 | Buy |
| 50-day EMA: | 76.91 | Buy |
| 200-day EMA: | 71.78 | Buy |
Intra-Cellular Therapies Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.18 | Buy |
| Relative Strength Index (14 RSI): | 76.99 | Buy |
| Chaikin Money Flow: | 460700 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (71.96 - 82.1) | Buy |
| Bollinger Bands (100): | (71.52 - 79.02) | Buy |
Intra-Cellular Therapies Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Intra-Cellular Therapies Stock
Is Intra-Cellular Therapies Stock a Buy?
- Intra-Cellular Therapies share price is 89.24 while ITCI 8-day simple moving average is 82.69, which is a Buy signal.
- The stock price of ITCI is 89.24 while Intra-Cellular Therapies 20-day SMA is 78.21, which makes it a Buy.
- Intra-Cellular Therapies 50-day simple moving average is 75.65 while ITCI share price is 89.24, making it a Buy technically.
- ITCI stock price is 89.24 and Intra-Cellular Therapies 200-day simple moving average is 72.06, creating a Buy signal.
ITCI Technical Analysis vs Fundamental Analysis
Buy
63
Intra-Cellular Therapies (ITCI)
is a Buy
Is Intra-Cellular Therapies a Buy or a Sell?
-
Intra-Cellular Therapies stock is rated a Buy
The current Intra-Cellular Therapies [ITCI] share price is $89.24. The Score for ITCI is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
Intra-Cellular Therapies Stock Info
Market Cap:
9.46B
Price in USD:
89.24
Share Volume:
507.24K
Intra-Cellular Therapies 52-Week Range
52-Week High:
89.44
52-Week Low:
52.88
Buy
63
Intra-Cellular Therapies (ITCI)
is a Buy
Intra-Cellular Therapies Share Price Forecast
-
What is the Intra-Cellular Therapies stock price today?
The Intra-Cellular Therapies stock price is 89.24 USD today. -
Will ITCI stock go up or go down?
Intra-Cellular Therapies> share price is forecast to RISE/FALL based on technical indicators -
Is Intra-Cellular Therapies overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Intra-Cellular Therapies is not overvalued.
Is Intra-Cellular Therapies Stock a Buy?
- Intra-Cellular Therapies share price is 89.24 while ITCI 8-day exponential moving average is 83.84, which is a Buy signal.
- The stock price of ITCI is 89.24 while Intra-Cellular Therapies 20-day EMA is 79.81, which makes it a Buy.
- Intra-Cellular Therapies 50-day exponential moving average is 76.91 while ITCI share price is 89.24, making it a Buy technically.
- ITCI stock price is 89.24 and Intra-Cellular Therapies 200-day simple moving average is 71.78, creating a Buy signal.
Fundamental Analysis of Intra-Cellular Therapies
Is Intra-Cellular Therapies a good investment?
- Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.96 per share, and an increase next year of $0.91 per share.
Technical Analysis of Intra-Cellular Therapies
Should I short Intra-Cellular Therapies stock?
- ITCI Moving Average Covergence Divergence (MACD) indicator is 3.18, suggesting Intra-Cellular Therapies is a Buy
- Intra-Cellular Therapies Relative Strength Index (RSI) is 76.99, which suggest Intra-Cellular Therapies is overbought
- The Bollinger Bands (25) for Intra-Cellular Therapies is (71.96 - 82.1), which suggest Intra-Cellular Therapies is a Buy
- The Bollinger Bands (100) for Intra-Cellular Therapies is (71.52 - 79.02), which suggest Intra-Cellular Therapies is a Buy
* Intra-Cellular Therapies stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.